How Corona Vaccine was made on mRNA technology?

India has got approval for its first mRNA technology-based vaccine to be used in an emergency. The happiness of this vaccine is more because it will be applied to all people after the age of 18 in an emergency and it is completely different from the rest of the vaccines.

Let us know how this vaccine was made and what is the story behind making it. Actually, a Pune-based company has made this vaccine and it is the first indigenous vaccine based on new technology. It is mandatory to keep this vaccine at a temperature of 2-4 degrees.

This vaccine is the one that was used globally for human trials. Last month, the Biopharma company of Genoa issued a statement regarding the Phase-3 trial of its vaccine. During the trial, 4000 people were tested. This technology was till now in the US but now it has come to india as well.

This is how the vaccine will work-

Actually, when a virus or bacteria attacks our body, mRNA technology sends a message to our cells to make proteins to fight against that virus or bacteria. This gives our immune system the necessary protein it needs and our Antibodies are made in the body and are capable of fighting the virus. This is the first time that such a vaccine has been made in India.

This is how the vaccine is being made-

Storing this vaccine in india is a big challenge because in western countries it is kept at zero temperature, but the temperature of india is very high. Therefore it has been converted from liquid to powder and made to be stored in the freeze. Through the lyophilization process, all its water is dried, and later it is frozen so that the ice turns into vapor.

Lyophilization This technique is not new but its use in this vaccine is new. Genoa officials said that many people have worked hard on its trial, first, it was tested on animals so that its safety could be checked, then under Phase 1 and 2, it was trialed on humans. The domestic mRNA vaccine platform will also be able to tackle other infectious diseases like TB, Dengue, Malaria, and Rare Genetic Diseases.